Lenacapavir HIV Prevention Injection to Reach Too Few
South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan…. Membership Required You must be a member to access this...
Sakeliga’s NHI Legal Battle for Constiutional Justice
Learn about Sakeliga's NHI legal battle as they challenge the constitutionality of South Africa's National Health Insurance plan.
Lenacapavir for HIV Prevention in South Africa
South Africa will introduce lenacapavir for HIV prevention in 2026, offering a new hope in the fight against HIV.